首页|白细胞介素-38对乳腺癌患者CD8+T淋巴细胞功能的影响

白细胞介素-38对乳腺癌患者CD8+T淋巴细胞功能的影响

扫码查看
目的 探讨白细胞介素-38(IL-38)在乳腺癌患者中的表达及其对CD8+T细胞功能的调控作用.方法 纳入2020 年7 月—2022 年9 月在新乡医学院第一附属医院就诊的44 例乳腺癌患者、25 例乳腺良性肿瘤患者和20 例对照者.分离所有受试者的血浆和外周血单个核细胞,分离乳腺癌患者肿瘤组织中的肿瘤浸润淋巴细胞,纯化CD8+T细胞.应用酶联免疫吸附试验(ELISA)检测血浆IL-38 蛋白水平,应用实时定量PCR检测组织IL-38 mRNA相对表达量.使用重组人IL-38 刺激乳腺癌患者外周血和肿瘤组织分离的CD8+T细胞,建立CD8+T细胞与乳腺癌细胞系MCF-7 的共培养系统,通过测定乳酸脱氢酶水平计算靶细胞死亡比例,ELISA法检测培养上清中穿孔素、颗粒酶B、干扰素-γ和肿瘤坏死因子-α(TNF-α)水平,流式细胞术检测CD8+T细胞的免疫检查点分子表达.结果 乳腺癌患者血浆IL-38 水平(74.23±19.88 pg/mL)高于乳腺良性肿瘤患者(62.87±16.27 pg/mL,P=0.018)和对照者(61.77±12.75 pg/mL,P=0.013).乳腺癌患者肿瘤组织中IL-38 mRNA相对表达量显著高于癌旁组织(1.57±0.22 vs.1.00±0.18,P<0.001).外周血和肿瘤浸润CD8+T细胞诱导靶细胞死亡比例、穿孔素和颗粒酶B分泌在直接接触共培养组中的水平高于间接接触共培养组(P<0.05),但干扰素-γ和TNF-α分泌水平在直接接触共培养组和间接接触共培养组之间的差异无统计学意义(P>0.05).在直接接触共培养组内,靶细胞死亡比例、穿孔素、颗粒酶B、干扰素-γ、TNF-α在IL-38 刺激组中的水平低于无刺激组(P<0.05).在间接接触共培养组内,靶细胞死亡比例、干扰素-γ、TNF-α在IL-38 刺激组中的水平亦低于无刺激组(P<0.05),但穿孔素和颗粒酶B水平在间接接触共培养组内的IL-38 刺激组和无刺激组之间的差异无统计学意义(P>0.05).CD8+T细胞中免疫检查点分子表达水平在无刺激组和IL-38 刺激组之间的差异均无统计学意义(P>0.05).结论 乳腺癌患者中高表达的IL-38 可能参与诱导CD8+T细胞功能衰竭.
Effect of interleukin-38 to CD8+T lymphocyte function in patients with breast cancer
Objective The objective of this study was to investigate the expression of interleukin-38(IL-38)in patients with breast cancer and its regulatory function to CD8+T cell activity.Methods 44 patients with breast cancer,25 patients with benign breast tumor,and 20 controls,who were treated in the First Affiliated Hospital of Xinxiang Medical University from July 2020 and Sep-tember 2022.Mononuclear cells from plasma and peripheral blood of all subjects were isolated,tumor-infiltrating lymphocytes from tumor tissues of breast cancer patients were isolated,and CD8+T cells were purified.IL-38 protein level in the plasma was measured by enzyme-linked immunosorbent assay(ELISA).The relative level of IL-38 mRNA in the tissue was semi-quantified by real-time quantitative PCR.Recombinant human IL-38 was used to stimulate CD8+T cells from peripheral blood and tumor tissue from patients with breast cancer.A co-culture system was established between CD8+T cells and breast cancer MCF-7 cell line.The percentage of target cell death was calculated by measuring lactate dehydrogenase level in the supernatants.The levels of perforin,granzyme B,inter-feron-γ and tumor necrosis factor-α(TNF-α)in the supernatants were measured by ELISA.The immune checkpoint molecules ex-pression in CD8+T cells were detected by flow cytometry.Results The levels of plasma IL-38 were significantly higher in patients with breast cancer(74.23±19.88 pg/mL)compared with in patients with benign breast tumor(62.87±16.27 pg/mL,P=0.018)and controls(61.77±12.75 pg/mL,P=0.013).The relative expression of IL-38 mRNA in tumor tissues was significantly higher than in para-tumor tissues(1.57±0.22 vs.1.00±0.18,P<0.001).The proportion of target cell death induced by peripheral and tumor-in-filtrating CD8+T cells,and the levels of perforin and granzyme B secretion in direct contact co-culture group were higher than those in indirect contact co-culture group(P<0.05).There were no significant differences of either interferon-γ or TNF-α levels between di-rect contact and indirect contact co-culture group(P>0.05).In the direct contact co-culture group,the levels of target cell death pro-portion,perforin,granzyme B,interferon-γ and TNF-α l in the IL-38 stimulation group were lower than those in the non-stimulation group(P<0.05).In the indirect contact co-culture group,the target of cell death proportion,interferon-γ and TNF-α the IL-38 stimulation group were also lower than those in the non-stimulation group(P<0.05).However,there were no statistical differences of either perforin or granzyme B levels between the IL-38 stimulation group and non-stimulation group within the indirect contact co-culture group(P>0.05).There were also no differences in the levels of immune checkpoint molecules in CD8+T cells between the non-stimulation group and the IL-38 stimulation group(P>0.05).Conclusion Highly expressed IL-38 in patients with breast cancer may be involved in inducing CD8+T cell functional failure.

Breast cancerInterleukin-38CD8+T-lymphocytesAnti-tumor

郑鹏飞、董良鹏、高延鑫、张一夫、秦双

展开 >

新乡医学院第一附属医院甲状腺乳腺外科(卫辉 453100)

乳腺癌 白细胞介素-38 CD8阳性T淋巴细胞 抗肿瘤

2024

实用肿瘤学杂志
黑龙江省,辽宁省,吉林省肿瘤防治办公室

实用肿瘤学杂志

CSTPCD
影响因子:0.528
ISSN:1002-3070
年,卷(期):2024.38(1)
  • 2